Photo from wikipedia
The aim of this study was to estimate the 1‐year costs associated with treating diabetic macular oedema (DME) patients using current intravitreal anti‐vascular endothelial growth factor (anti‐VEGF) biologics compared with… Click to show full abstract
The aim of this study was to estimate the 1‐year costs associated with treating diabetic macular oedema (DME) patients using current intravitreal anti‐vascular endothelial growth factor (anti‐VEGF) biologics compared with the dexamethasone implant.
Keywords:
macular oedema;
endothelial growth;
anti vascular;
intravitreal anti;
vascular endothelial;
diabetic macular
Journal Title: Acta Ophthalmologica
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Acta Ophthalmologica
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!